• Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

T1D Staging: The Clinical Importance of Early Recognition

Opinion
Video

The panel outlines the stages of type 1 diabetes, focusing on the importance of early intervention to prevent complications of the disease.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

Grace Halsey
March 14th 2025
Article

A new economic evaluation estimates that semaglutide would need to drop its current price by 81.9% and tirzepatide by 30.5% to be cost effective.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Study: COVID-19 Pandemic Disruptions in Cancer Screening Show Uneven Recovery in 2023 / Image credit: ©sharafmaksumov/AdobeStock

Study: COVID-19 Pandemic Disruptions in Cancer Screening Show Uneven Recovery in 2023

Sydney Jennings
March 12th 2025
Article

Cervical cancer screening rates remained below prepandemic levels, while rates for breast and colorectal cancers rebounded from pandemic declines.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

FDA Approves First Rapid-Acting Insulin Biosimilar for Diabetes: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves First Rapid-Acting Insulin Biosimilar for Diabetes: Daily Dose

Sydney Jennings
March 3rd 2025
Article

Your daily dose of the clinical news you may have missed.

FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Diabetes

FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Diabetes

Patient Care Editorial Staff
February 14th 2025
Article

Merilog joins two long-acting insulin biosimilar products approved in 2021, bringing the total to three insulin biosimilars available in the United States.

© 2025 MJH Life Sciences

All rights reserved.